Fig. 1From: Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert®) in patients with hereditary angioedema: the SABHA studyBox plot showing the results of HAE-QoL surveys (medians are in bold)Back to article page